Hepatobiliary cancer: All efforts for one goal

Cancer Lett. 2016 Sep 1;379(2):164-5. doi: 10.1016/j.canlet.2016.03.044. Epub 2016 Apr 4.

Author

Affiliation

¹ Department of Molecular Oncology, Eastern Hepatobiliary Surgery Hospital & National Center of Liver Cancer, Second Military Medical University, Shanghai 200438, China. Electronic address: suchangqing@gmail.com.

PMID: 27054486
DOI: 10.1016/j.canlet.2016.03.044

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Animals
Antineoplastic Agents / therapeutic use
Biliary Tract Neoplasms* / drug therapy
Biliary Tract Neoplasms* / epidemiology
Biliary Tract Neoplasms* / metabolism
Biliary Tract Neoplasms* / pathology
Biomarkers, Tumor / metabolism
Humans
Liver Neoplasms* / drug therapy
Liver Neoplasms* / epidemiology
Liver Neoplasms* / metabolism
Liver Neoplasms* / pathology
Molecular Targeted Therapy
Risk Factors
Signal Transduction

Substances

Antineoplastic Agents
Biomarkers, Tumor